Literature DB >> 8078803

Cervical adenocarcinomas express markers common to gastric, intestinal, and pancreatobiliary epithelial cells.

P Tenti1, S Romagnoli, E Silini, R Zappatore, P Giunta, G Stella, L Carnevali.   

Abstract

Frequency and pattern of expression of eight markers of gastric, intestinal, and pancreatobiliary duct epithelial cells have been investigated by histochemical and immunohistochemical techniques in 85 cases of cervical adenocarcinomas. M1, a mucin antigen, and Cathepsin E (CaE), an aspartic proteinase, markers of normal gastric superficial/foveolar epithelial cells, are expressed in 40 and 55 tumors, respectively. Periodic acid-concanavalin A-reactive mucin or Pepsinogen (PG) II, markers of gastric mucus neck and pyloric gland cells, are found in 24 tumors, 13 of which also express M1 and CaE. CAR-5 and M3SI, markers of intestinal mucin, are expressed in 68 and 12 tumors and DU-PAN-2, marker of normal pancreatobiliary duct cells, is found in 46 tumors. All but two tumors express at least one of the eight markers studied, none express PG I, marker of gastric chief cells. The different histologic subtypes of cervical adenocarcinomas expressed to a variable degree both gastrointestinal and pancreatobiliary markers. Only endocervical type tumors, however, showed the full spectrum of mucosal pyloric type differentiation, including the expression of PGII which is not present in any other histotype. A correlation between expression of gastroenteropancreatic markers and tumor grade is not apparent in our series.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078803     DOI: 10.1016/S0344-0338(11)80406-1

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D Logsdon; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2011-09-20

2.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

3.  Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.

Authors:  Edmund J Keliher; Thomas Reiner; Sarah Earley; Jenna Klubnick; Carlos Tassa; Andrew J Lee; Sridhar Ramaswamy; Nabeel Bardeesy; Douglas Hanahan; Ronald A Depinho; Cesar M Castro; Ralph Weissleder
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

4.  Cathepsin E expression by normal and premalignant cervical epithelium.

Authors:  F Mota; J H Kanan; N Rayment; T Mould; A Singer; B M Chain
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 5.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

6.  Protease-activated drug development.

Authors:  Ki Young Choi; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-02-08       Impact factor: 11.556

Review 7.  A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature.

Authors:  Giovanna Giordano; Silvia Pizzi; Roberto Berretta; Tiziana D'Adda
Journal:  World J Surg Oncol       Date:  2012-01-11       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.